Tag: Hepatitis
Review: Multiple DAA Regimens Effective for HCV Genotype 1
Six DAA regimens show high SVR in HCV genotype 1 without cirrhosis, even with HIV co-infection
HBV Reactivation Seen With DAA Treatment of Chronic Hep C
HBV virological reactivation in four of seven patients with current HBV infection; none with past infection
Rates of Hepatitis C Testing Too Low in Baby Boomers
Screening rates remain low despite recommendations, researchers say
Short-Course Tocilizumab May Up Hep B Reactivation in RA
Three patients with chronic HBV infection had reactivation, but they were asymptomatic
Risk of Diabetes Down With HCV SVR in HIV/HCV Coinfection
Sustained viral response linked to reduction in risk of diabetes, trend toward reduced risk of renal failure
Sorafenib Effect on HCC Survival Depends on Hepatitis Status
Findings in meta-analysis of individual patient data for advanced unresectable hepatocellular carcinoma
Non-Liver-Related Critical Events Down With SVR in HCV+Cirrhosis
Study confirms reduction in critical events, liver-related or not
Ledipasvir-Sofosbuvir Effective for Chronic HCV in Adolescents
98 of 100 patients reached sustained virologic response at 12 weeks; no virologic failure observed
Chronic Hepatitis B Prevalence Higher in Those With T2DM
Findings based on comparison to adult-onset autoimmune diabetes, controls
Diabetes Ups Risk of HCC, Death in Patients With Hepatitis C
Diabetes increases risk of hepatocellular carcinoma development in patients with HCV
